Results Published in The Lancet Demonstrate Superiority of XGEVA(TM) (Denosumab)
- Details
- Category: Amgen
![Amgen Amgen](/images/stories/logo/amgen.gif)
Bayer and Onyx Initiate Phase III Trial of Nexavar® in Combination with Chemotherapy
- Details
- Category: Bayer
![Bayer Bayer](/images/stories/logo/bayer.gif)
Lundbeck delivers at the top-end of guidance and momentum is expected to continue in 2011
- Details
- Category: Lundbeck
![Lundbeck Lundbeck](/images/stories/logo/lundbeck.gif)
Sanofi Pasteur and International Vaccine Institute Partner against Dengue
- Details
- Category: Sanofi
![Sanofi-aventis Sanofi-aventis](/images/stories/logo/sanofi-aventis.gif)
ONGLYZA™ US label update regarding use in renally impaired adults with type 2 diabetes
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](/images/stories/logo/astrazeneca.gif)
Forest Laboratories to Acquire Clinical Data, Inc.
- Details
- Category: Financial
![Forest Laboratories Forest Laboratories](/images/stories/logo/forest.gif)
Novartis gains positive CHMP opinion for Rasilamlo(TM)
- Details
- Category: Novartis
![Novartis Novartis](/images/stories/logo/novartis_b.gif)
More Pharma News ...
- Sanofi-aventis to Acquire Genzyme for $74.00 in Cash per Share Plus Contingent Value Right
- Genzyme Reports Financial Results for Fourth Quarter of 2010 and Full Year
- Pfēnex Inc. and Boehringer Ingelheim Announce Non-Exclusive Strategic Agreement
- Lilly Marks Major Milestone for Mirror Portfolio
- First African country introduces GSK's pneumococcal vaccine
- New AVERROES Data Demonstrate Investigational Apixaban Superior to Aspirin
- Elan and Boehringer Ingelheim Announce Development and Manufacturing Agreement